MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis.
Journal
NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070
Informations de publication
Date de publication:
2019
2019
Historique:
received:
20
11
2018
revised:
08
07
2019
accepted:
13
07
2019
pubmed:
5
8
2019
medline:
17
9
2020
entrez:
5
8
2019
Statut:
ppublish
Résumé
The decline of voluntary bulbar functions such as speech and swallowing are among the clinical manifestations of amyotrophic lateral sclerosis (ALS) influencing a worst prognosis. Differential diagnosis between the contribution of upper motor neuron (UMN) and lower motor neuron degeneration to the bulbar impairment is often hard. Thinning and T2* hypointensity of the primary motor cortex have been recently suggested as possible MRI markers of UMN impairment in ALS patients, but little research has purposely targeted the orofacial region of the primary motor cortex (fM1). With the aim of finding an MRI marker of UMN impairment responsible for bulbar dysfunction, we investigated the T2* signal intensity of fM1 and the relationship with bulbar impairment in ALS patients. Fifty-five ALS patients were examined with 3 T MRI. Their fM1 was evaluated both qualitatively in terms of T2* signal intensity and quantitatively by measuring its magnetic susceptibility with Quantitative Susceptibility Mapping (QSM). Bulbar functions were assessed clinically, by neurological examination and using the items 1-3 of the ALSFRS-R, and with neurophysiological tests. The marked hypointensity of fM1 was detected in 25% of ALS patients, including all patients with bulbar onset, and was 74% sensitive, 100% specific and 91% accurate in diagnosing functional bulbar impairment. Such hypointensity involved the middle and ventral part of fM1 and was usually visible in both hemispheres. The magnetic susceptibility was significantly higher in patients with marked fM1 hypointensity than in the other patients (p ≤ .001). The relationship with clinical and neurophysiological data suggests that such feature could be a marker of UMN degeneration for voluntary bulbar functions.
Identifiants
pubmed: 31377555
pii: S2213-1582(19)30284-0
doi: 10.1016/j.nicl.2019.101934
pmc: PMC6698695
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
101934Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Références
Clin Neurophysiol. 2001 Dec;112(12):2190-201
pubmed: 11738189
Eur J Neurol. 2006 Jul;13(7):789-92
pubmed: 16834713
J Neurol Neurosurg Psychiatry. 1970 Jun;33(3):338-57
pubmed: 5431724
Neurol Clin. 2015 Nov;33(4):855-76
pubmed: 26515626
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
Eur J Neurol. 2010 Apr;17(4):526-e20
pubmed: 20136647
J Neuroimaging. 2015 May-Jun;25(3):443-51
pubmed: 24888543
Brain. 1998 Jun;121 ( Pt 6):1099-108
pubmed: 9648545
Clin Neurophysiol. 2016 Jul;127(7):2643-60
pubmed: 27291884
Acta Neuropathol. 2002 Sep;104(3):249-59
pubmed: 12172910
AMA Arch Neurol Psychiatry. 1953 Feb;69(2):171-92
pubmed: 13007227
Neuroimage Clin. 2016 May 02;12:965-969
pubmed: 27995062
J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):513-515
pubmed: 30299162
J Neurol. 2013 Nov;260(11):2856-64
pubmed: 23996101
AJNR Am J Neuroradiol. 2015 Mar;36(3):461-6
pubmed: 25376811
Brain. 2008 Jun;131(Pt 6):1540-50
pubmed: 18469020
Ther Clin Risk Manag. 2013;9:483-9
pubmed: 24348042
J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):113-5
pubmed: 12122165
Neuroimage. 1995 Jun;2(2):89-101
pubmed: 9343592
Brain. 1997 Jan;120 ( Pt 1):141-57
pubmed: 9055804
Clin Neurophysiol. 2008 Mar;119(3):497-503
pubmed: 18164242
AJNR Am J Neuroradiol. 2018 Jan;39(1):63-69
pubmed: 29122765
BMC Neurosci. 2018 Mar 13;19(1):11
pubmed: 29529995
Amyotroph Lateral Scler. 2010 Oct;11(5):424-9
pubmed: 19929748
Muscle Nerve. 2011 May;43(5):636-42
pubmed: 21484822
Am J Pathol. 1992 Mar;140(3):691-707
pubmed: 1347673
PLoS One. 2012;7(4):e35241
pubmed: 22529995
AJNR Am J Neuroradiol. 2016 Mar;37(3):455-61
pubmed: 26680464
Orphanet J Rare Dis. 2009 Feb 03;4:3
pubmed: 19192301
J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):766-73
pubmed: 23085933
J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):6-11
pubmed: 18079297
Pract Neurol. 2016 Dec;16(6):500-501
pubmed: 28120789
Lancet. 2011 Mar 12;377(9769):942-55
pubmed: 21296405
J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):288-94
pubmed: 25121571
J Neurol Neurosurg Psychiatry. 2003 Dec;74 Suppl 4:iv32-iv47
pubmed: 14645465
Acta Neurol Scand. 2018 Feb;137(2):262-271
pubmed: 29082510
Nat Clin Pract Neurol. 2008 Jul;4(7):366-74
pubmed: 18560390
Neuroimage Clin. 2014 Feb 27;4:436-43
pubmed: 24624329
J Neurol Neurosurg Psychiatry. 2012 Jun;83(6):659-62
pubmed: 22496581
J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):740-6
pubmed: 21402743
Neurosci Biobehav Rev. 2014 Jan;38:135-59
pubmed: 24239732